| Category | Amount |
|---|---|
| NONE |
| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Identifier | Return Reference | Explanation |
|---|---|---|
| FORM 990-PF, PART IX-A | FORM 990-PF, PART IX-A | SUMMARY OF DIRECT CHARITABLE ACTIVITIES THE FOUNDATION CONDUCTED ACTIVITIES DESCRIBED IN CODE SECTION 170(C)(2)(B) BY DISTRIBUTING MEDICINES, PRESCRIPTION DRUGS, AND OTHER PHARMACEUTICAL PRODUCTS AND MEDICAL SUPPLIES (PHARMACEUTICAL PRODUCTS), DONATED TO IT BY ELI LILLY AND COMPANY (DONOR) TO THE ILL, NEEDY, AND INFANTS WHO MET THE FOUNDATION'S ELIGIBILITY REQUIREMENTS (ELIGIBLE PATIENTS). THE PHARMACEUTICAL PRODUCTS IT RECEIVED FROM THE DONOR WERE DISTRIBUTED FOR CHARITABLE PURPOSES AND AT NO CHARGE, FOR THE CARE OF ELIGIBLE PATIENTS. DURING 2020, THE FOUNDATION DISTRIBUTED OVER $1.6 BILLION OF PRODUCTS TO OVER 159,000 ELIGIBLE PATIENTS FOR MENTAL HEALTH, DIABETES, CARDIAC CARE, MEN'S HEALTH, OSTEOPOROSIS, ONCOLOGY, AUTOIMMUNE, MIGRAINES, PSORIASIS AND GROWTH HORMONE DISORDERS. |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| DIST OF PHARMACEUTICALS | 1,646,080,348 | 1,646,080,348 |